Inventor
PIERCE ALBERT CHARLES
US24 patents
⚠️ This page may combine multiple inventors who share the name “PIERCE ALBERT CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
23 patentsUS9925188B2Mar 27, 2018
DNA-PK inhibitors and uses thereof
VERTEX PHARMA24 citations98
US9376448B2Jun 28, 2016
DNA-PK inhibitors
VERTEX PHARMA46 citations98
US9592232B2Mar 14, 2017
DNA-PK inhibitors
VERTEX PHARMA24 citations94
US9878993B2Jan 30, 2018
DNA-PK inhibitors for treatment of cancer
VERTEX PHARMA10 citations92
US9359380B2Jun 7, 2016
DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9340557B2May 17, 2016
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9296701B2Mar 29, 2016
DNA-PK inhibitors
VERTEX PHARMA21 citations92
US10973830B2Apr 13, 2021
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020
DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10501439B2Dec 10, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10442791B2Oct 15, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10391095B2Aug 27, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10258627B2Apr 16, 2019
DNA-PK inhibitors
VERTEX PHARMA4 citations84
US10076521B2Sep 18, 2018
DNA-PK inhibitors
VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018
Substituted benzooxadiazole DNA-PK inhibitors
VERTEX PHARMA5 citations84
US9676759B2Jun 13, 2017
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
VERTEX PHARMA8 citations83
US10183933B2Jan 22, 2019
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
VERTEX PHARMA1 citations72
US10118904B2Nov 6, 2018
Triazoles for the treatment of Demyelinating Diseases
VERTEX PHARMA3 citations68
US12251387B2Mar 18, 2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11813267B2Nov 14, 2023
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11021465B2Jun 1, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11008305B2May 18, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US10766869B2Sep 8, 2020
Triazoles for the treatment of demyelinating dieases
VERTEX PHARMA0 citations48